Circulating white blood cell traits and colorectal cancer risk: A Mendelian randomisation study
Open Access
- 14 August 2023
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 154 (1) , 94-103
Abstract
Observational studies have suggested a protective role for eosinophils in colorectal cancer (CRC) development and implicated neutrophils, but the causal relationships remain unclear. Here, we aimed to estimate the causal effect of circulating white blood cell (WBC) counts (N = ~550 000) for basophils, eosinophils, monocytes, lymphocytes and neutrophils on CRC risk (N = 52 775 cases and 45 940 controls) using Mendelian randomisation (MR). For comparison, we also examined this relationship using individual‐level data from UK Biobank (4043 incident CRC cases and 332 773 controls) in a longitudinal cohort analysis. The inverse‐variance weighted (IVW) MR analysis suggested a protective effect of increased basophil count and eosinophil count on CRC risk [OR per 1‐SD increase: 0.88, 95% CI: 0.78‐0.99, P = .04; OR: 0.93, 95% CI: 0.88‐0.98, P = .01]. The protective effect of eosinophils remained [OR per 1‐SD increase: 0.88, 95% CI: 0.80‐0.97, P = .01] following adjustments for all other WBC subtypes, to account for genetic correlation between the traits, using multivariable MR. A protective effect of increased lymphocyte count on CRC risk was also found [OR: 0.84, 95% CI: 0.76‐0.93, P = 6.70e‐4] following adjustment. Consistent with MR results, a protective effect for eosinophils in the cohort analysis in the fully adjusted model [RR per 1‐SD increase: 0.96, 95% CI: 0.93‐0.99, P = .02] and following adjustment for the other WBC subtypes [RR: 0.96, 95% CI: 0.93‐0.99, P = .001] was observed. Our study implicates peripheral blood immune cells, in particular eosinophils and lymphocytes, in CRC development, highlighting a need for mechanistic studies to interrogate these relationships.Keywords
All Related Versions
Funding Information
- Cancer Research UK (C18281/A29019)
- Diabetes UK (17/0005587)
- Medical Research Council (MC_UU_00011/1, MC_UU_00011/4, MR/N0137941/1)
- National Cancer Institute (R21CA230486)
- NIHR Bristol Biomedical Research Centre (BRC‐1215‐2001)
- Wellcome Trust (202802/Z/16/Z, 204813/Z/16/Z, 217065/Z/19/Z)
- World Cancer Research Fund International (IIG_2019_2009)
This publication has 36 references indexed in Scilit:
- Combining information on multiple instrumental variables in Mendelian randomization: comparison of allele score and summarized data methodsStatistics in Medicine, 2015
- A global reference for human genetic variationNature, 2015
- A Multivariate Genome-Wide Association Analysis of 10 LDL Subfractions, and Their Response to Statin Treatment, in 1868 CaucasiansPLOS ONE, 2015
- Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regressionInternational Journal of Epidemiology, 2015
- IgE/FcεRI-Mediated Antigen Cross-Presentation by Dendritic Cells Enhances Anti-Tumor Immune ResponsesCell Reports, 2015
- Mendelian randomization: genetic anchors for causal inference in epidemiological studiesHuman Molecular Genetics, 2014
- Large-scale genetic study in East Asians identifies six new loci associated with colorectal cancer riskNature Genetics, 2014
- Bias in causal estimates from Mendelian randomization studies with weak instrumentsStatistics in Medicine, 2011
- Human Eosinophils Exert TNF-α and Granzyme A-Mediated Tumoricidal Activity toward Colon Carcinoma CellsThe Journal of Immunology, 2010
- ‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease?*International Journal of Epidemiology, 2003